Literature DB >> 7002186

Kinetics and metabolism of paracetamol and phenacetin.

L F Prescott.   

Abstract

1 The rate of absorption of oral paracetamol depends on the rate of gastric emptying and is usually rapid and complete. The mean systemic availability is about 75%. 2 Paracetamol is extensively metabolized and the plasma half-life is 1.5-2.5 hours. About 55% and 30% of a therapeutic dose is excreted in the urine as glucuronide and sulphate conjugates, respectively, whereas mercapturic acid and cysteine conjugates (representing conversion to a potentially toxic intermediate metabolite) each account for some 4% of the dose. Paracetamol metabolism is age- and dose-dependent. 3 With hepatotoxic doses, paracetamol metabolism is impaired and the half-life prolonged. Sulphate conjugation is saturated and the proportion excreted as mercapturic acid and cysteine conjugates is increased. 4 The renal clearance of paracetamol depends on urine flow rate by not pH. The renal clearances of the glucuronide and sulphate conjugates often exceed the glomerular filtration rate and are independent of urine flow and pH. 5 Phenacetin absorption depends on formulation. It is extensively metabolized to paracetamol and minor metabolites are probably responsible for toxicity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002186      PMCID: PMC1430174          DOI: 10.1111/j.1365-2125.1980.tb01812.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  45 in total

1.  Some factors affecting the absorption of paracetamol.

Authors:  I J McGilveray; G L Mattok
Journal:  J Pharm Pharmacol       Date:  1972-08       Impact factor: 3.765

2.  Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy.

Authors:  J Raaflaub; U C Dubach
Journal:  Klin Wochenschr       Date:  1969-12-01

3.  The comparative metabolism of phenacetin and N-acetyl-p-aminophenol in man, with particular reference to effects on the kidney.

Authors:  L F Prescott; M Sansur; W Levin; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1968 Sep-Oct       Impact factor: 6.875

4.  The effects of particle size on the absorption of phenacetin in man. A correlation between plasma concentration of phenacetin and effects on the central nervous system.

Authors:  L F Prescott; R F Steel; W R Ferrier
Journal:  Clin Pharmacol Ther       Date:  1970 Jul-Aug       Impact factor: 6.875

5.  The metabolism of phenacetin in patients with enal diseas.

Authors:  L F Prescott
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

6.  The metabolism of acetophenetidine. Isolation and characterization of S-(1-acetamido-4-hydroxyphenyl)-cysteine, a metabolite of acetophenetidine.

Authors:  O R Jagenburg; K Toczko
Journal:  Biochem J       Date:  1964-09       Impact factor: 3.857

7.  Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide.

Authors:  G Levy; H Yamada
Journal:  J Pharm Sci       Date:  1971-02       Impact factor: 3.534

8.  A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man.

Authors:  A J Cummings; M L King; B K Martin
Journal:  Br J Pharmacol Chemother       Date:  1967-02

9.  [Studies on the oxidative metabolism of phenacetin in rats].

Authors:  H Büch; K Pfleger; W Rummel; V Ullrich; D Hey; H Staudinger
Journal:  Biochem Pharmacol       Date:  1967-12       Impact factor: 5.858

10.  Some new aspects of the metabolism of phenacetin in the rat.

Authors:  R Nery
Journal:  Biochem J       Date:  1971-04       Impact factor: 3.857

View more
  117 in total

1.  Gastric emptying and acetaminophen: lessons learnt from the several co-administered drugs on the experimental design.

Authors:  Nuggehally R Srinivas
Journal:  Eur J Clin Pharmacol       Date:  2015-09-08       Impact factor: 2.953

2.  The effect of age on glucuronidation and sulphation of paracetamol by human liver fractions.

Authors:  B Herd; H Wynne; P Wright; O James; K Woodhouse
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

3.  Maximum entropy and drug absorption.

Authors:  M K Charter; S F Gull
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

4.  Lack of effect of paracetamol on the pharmacokinetics and metabolism of codeine in man.

Authors:  A Somogyi; F Bochner; Z R Chen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  [Not Available].

Authors:  K Menges
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

6.  Computational models to assign biopharmaceutics drug disposition classification from molecular structure.

Authors:  Akash Khandelwal; Praveen M Bahadduri; Cheng Chang; James E Polli; Peter W Swaan; Sean Ekins
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

Review 7.  Evidence for the changing regimens of acetylcysteine.

Authors:  Angela L Chiew; Geoffrey K Isbister; Stephen B Duffull; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-11-23       Impact factor: 4.335

8.  Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism.

Authors:  Albert Goday Arno; Magí Farré; Jose Rodríguez-Morató; Jose M Ramon; Clara Pérez-Mañá; Esther Papaseit; Ester Civit; Klaus Langohr; Marcel Lí Carbó; David Benaiges Boix; Olga Castañer Nino; Juana Antonia Flores Le Roux; Manuel Pera; Luis Grande; Rafael de la Torre
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

9.  Passage of paracetamol into breast milk and its subsequent metabolism by the neonate.

Authors:  L J Notarianni; H G Oldham; P N Bennett
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

10.  Time-dependent variations in the organ extraction ratios of acetaminophen in rat.

Authors:  P M Bélanger; M Lalande; F Doré; G Labrecque
Journal:  J Pharmacokinet Biopharm       Date:  1987-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.